- TEVA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $163.4 million.
- TEVA is down 3% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in TEVA with the Ticky from Trade-Ideas. See the FREE profile for TEVA NOW at Trade-Ideas More details on TEVA: Teva Pharmaceutical Industries Limited, together with its subsidiaries, develops, manufactures, sells, and distributes pharmaceutical products worldwide. The company offers generic pharmaceutical products; and basic chemicals, as well as specialized product families. The stock currently has a dividend yield of 2.2%. TEVA has a PE ratio of 35.0. Currently there are 10 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and 10 rate it a hold. The average volume for Teva Pharmaceutical Industries has been 4.0 million shares per day over the past 30 days. Teva has a market cap of $44.6 billion and is part of the health care sector and drugs industry. Shares are up 30.4% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.